Works matching IS 02692813 AND DT 2025 AND VI 61 AND IP 3
Results: 60
Editorial: High Baseline ALT Level Confers Risk of Hepatic Adverse Events During Immune Checkpoint Inhibitors Treatment: A Call for Caution—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 714, doi. 10.1111/apt.18491
- By:
- Publication type:
- Article
Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 737, doi. 10.1111/apt.18489
- By:
- Publication type:
- Article
Letter: Identifying the Best Model for Predicting Post‐SVR HCC—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 750, doi. 10.1111/apt.18488
- By:
- Publication type:
- Article
Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 706, doi. 10.1111/apt.18485
- By:
- Publication type:
- Article
Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A 'Precision Medicine' Study: Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 743, doi. 10.1111/apt.18483
- By:
- Publication type:
- Article
Editorial: Heads or Tails in the Treatment of Functional Dyspepsia—Does the Side of the Coin Matter? Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 733, doi. 10.1111/apt.18479
- By:
- Publication type:
- Article
Lubiprostone Reduces Fat Content on MRI‐PDFF in Patients With MASLD: A 48‐Week Randomised Controlled Trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 628, doi. 10.1111/apt.18478
- By:
- Publication type:
- Article
Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 735, doi. 10.1111/apt.18476
- By:
- Publication type:
- Article
Editorial: Where to Start in Ulcerative Colitis?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 739, doi. 10.1111/apt.18475
- By:
- Publication type:
- Article
Analysis of Antroduodenal Motility in Patients With Hypermobility Spectrum Disorders/Hypermobile Ehlers–Danlos Syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 702, doi. 10.1111/apt.18471
- By:
- Publication type:
- Article
Editorial: Evaluating the Prevalence of Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinaemia—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 729, doi. 10.1111/apt.18470
- By:
- Publication type:
- Article
Editorial: PIVKA‐II Facilitates Risk Stratification for HCC Following HCV Cure—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 585, doi. 10.1111/apt.18469
- By:
- Publication type:
- Article
The Proteomics of MASLD Progression: Insights From Functional Analysis to Drive the Development of New Therapeutic Solutions.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 614, doi. 10.1111/apt.18468
- By:
- Publication type:
- Article
Correction to 'Editorial: Unravelling the fibres—low dietary fibre may lower risk of developing IBD'.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 752, doi. 10.1111/apt.18467
- Publication type:
- Article
Management of Perianal Fistulizing Crohn's Disease According to Principles of Wound Repair.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 600, doi. 10.1111/apt.18466
- By:
- Publication type:
- Article
Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 721, doi. 10.1111/apt.18465
- By:
- Publication type:
- Article
Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 746, doi. 10.1111/apt.18464
- By:
- Publication type:
- Article
Editorial: Hepatitis D Screening—DAS (Delta Virus Awareness and Screening) Approach in Primary Care. Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 725, doi. 10.1111/apt.18461
- By:
- Publication type:
- Article
Letter: Increased Prevalence of Visceral Obesity in Nonresponder Patients With Primary Biliary Cholangitis Based on Computed Tomography—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 591, doi. 10.1111/apt.18457
- By:
- Publication type:
- Article
Editorial: Heads or Tails in the Treatment of Functional Dyspepsia—Does the Side of the Coin Matter?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 731, doi. 10.1111/apt.18456
- By:
- Publication type:
- Article
Editorial: Striving for Equitable Care in Ulcerative Colitis—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 718, doi. 10.1111/apt.18454
- By:
- Publication type:
- Article
Editorial: Evaluating the Prevalence of Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinemia.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 727, doi. 10.1111/apt.18453
- By:
- Publication type:
- Article
Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 433, doi. 10.1111/apt.18451
- By:
- Publication type:
- Article
Letter: Insulin‐Like Growth Factor‐1 in Cirrhosis Is Linked to Hepatic Dysfunction and Fibrogenesis and Predicts Liver‐Related MortAlity—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 595, doi. 10.1111/apt.18452
- By:
- Publication type:
- Article
Editorial: Targeting the Future of Eosinophilic Oesophagitis Management.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 587, doi. 10.1111/apt.18449
- By:
- Publication type:
- Article
Editorial: Hepatitis D Screening—DAS (Delta Virus Awareness and Screening) Approach in Primary Care.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 723, doi. 10.1111/apt.18446
- By:
- Publication type:
- Article
Editorial: PIVKA‐II Facilitates Risk Stratification for HCC Following HCV Cure.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 583, doi. 10.1111/apt.18444
- By:
- Publication type:
- Article
Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 444, doi. 10.1111/apt.18443
- By:
- Publication type:
- Article
Long‐Term Outcomes of an Infliximab‐First Versus Vedolizumab‐First Treatment Strategy in Biologic‐Naïve Patients With Ulcerative Colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 693, doi. 10.1111/apt.18441
- By:
- Publication type:
- Article
Letter: Increased Prevalence of Visceral Obesity in Nonresponder Patients With Primary Biliary Cholangitis Based on Computed Tomography.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 589, doi. 10.1111/apt.18440
- By:
- Publication type:
- Article
Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 682, doi. 10.1111/apt.18438
- By:
- Publication type:
- Article
Letter: Identifying the Best Model for Predicting Post‐SVR HCC.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 748, doi. 10.1111/apt.18437
- By:
- Publication type:
- Article
Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 719, doi. 10.1111/apt.18436
- By:
- Publication type:
- Article
Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 675, doi. 10.1111/apt.18435
- By:
- Publication type:
- Article
In‐Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 667, doi. 10.1111/apt.18433
- By:
- Publication type:
- Article
Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 658, doi. 10.1111/apt.18430
- By:
- Publication type:
- Article
Editorial: Helicobacter pylori Antimicrobial Susceptibility Testing—An Expanding Toolbox. Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 581, doi. 10.1111/apt.18429
- By:
- Publication type:
- Article
Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 744, doi. 10.1111/apt.18428
- By:
- Publication type:
- Article
Mortality of Acute Kidney Injury in Cirrhosis: A Systematic Review and Meta‐Analysis of Over 5 Million Patients Across Different Clinical Settings.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 420, doi. 10.1111/apt.18426
- By:
- Publication type:
- Article
Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A 'Precision Medicine' Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 741, doi. 10.1111/apt.18425
- By:
- Publication type:
- Article
Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 651, doi. 10.1111/apt.18424
- By:
- Publication type:
- Article
Editorial: Striving for Equitable Care in Ulcerative Colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 716, doi. 10.1111/apt.18423
- By:
- Publication type:
- Article
Editorial: High Baseline ALT Level Confers Risk of Hepatic Adverse Events During Immune Checkpoint Inhibitors Treatment: A Call for Caution.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 712, doi. 10.1111/apt.18422
- By:
- Publication type:
- Article
Management of Patients With Refractory Reflux‐Like Symptoms Despite Proton Pump Inhibitor Therapy: Evidence‐Based Consensus Statements.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 636, doi. 10.1111/apt.18420
- By:
- Publication type:
- Article
Early HBcrAg and Anti‐HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation—A Pooled Analysis of Two Clinical Trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 570, doi. 10.1111/apt.18416
- By:
- Publication type:
- Article
Coronary Artery Disease and Major Adverse Cardiovascular Events in People With Hepatic Steatosis at Low Atherosclerotic Cardiovascular Disease Risk.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 558, doi. 10.1111/apt.18415
- By:
- Publication type:
- Article
Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 550, doi. 10.1111/apt.18413
- By:
- Publication type:
- Article
Development and Validation of a PIVKA‐II‐Based Model for HCC Risk Stratification in Patients With HCV‐Related Cirrhosis Successfully Treated With DAA.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 538, doi. 10.1111/apt.18409
- By:
- Publication type:
- Article
Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real‐World Multicentre Study in Japan.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 524, doi. 10.1111/apt.18406
- By:
- Publication type:
- Article
Black Race is Associated with Decreased Exposure to Advanced Therapies and Worse Outcomes in Individuals with Ulcerative Colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 3, p. 513, doi. 10.1111/apt.18405
- By:
- Publication type:
- Article